Inocras Inc.

Inocras pioneers healthcare advancements through whole genome sequencing, offering personalized patient care at the forefront of precision health. Specializing in cancer and rare diseases, our advanced diagnostics platform provides actionable insights by analyzing each individual's unique genomic makeup. Standard panel testing looks at less than 0.

1% of your genome, while our whole genome bioinformatics platform captures over 99%, offering enhanced clarity and comprehensive analysis for better treatment options. Whether you're navigating cancer treatment or rare disease diagnosis, our genomic tests, such as CancerVision and RareVision, provide valuable insights for informed decision-making. We support patients, providers, and researchers with user-friendly reports, genetic counseling, and connections to clinical trials.

Join us in unlocking the potential of whole genome sequencing to transform how genetically driven diseases are diagnosed and treated. Benefit from precision health with Inocras